OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹17 Cr | ₹11 Cr | ₹6.33 Cr | ₹8.67 Cr | ₹3.19 Cr |
What is the latest Cash Flow from Financing Activities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹17 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹6.33 Cr |
Mar2021 | ₹8.67 Cr |
Mar2020 | ₹3.19 Cr |
How is Cash Flow from Financing Activities of OXYGENTA PHARMACEUTICAL Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹17 Cr | 52.64 | |
Mar2023 | ₹11 Cr | 77.26 | |
Mar2022 | ₹6.33 Cr | -26.94 | |
Mar2021 | ₹8.67 Cr | 171.78 | |
Mar2020 | ₹3.19 Cr | - |
Compare Cash Flow from Financing Activities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹217.2 Cr | -15.8% | -17.6% | -23.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,893.0 Cr | 1% | 4.8% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹171,976.0 Cr | 11.2% | 7.4% | 10.5% | Stock Analytics | |
CIPLA | ₹126,137.0 Cr | 3.2% | -0.1% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,712.0 Cr | 0.3% | -1.6% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 1.3% | -3% | -6.5% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -15.8% |
-17.6% |
-23.5% |
SENSEX | 1.6% |
1.7% |
1.8% |
You may also like the below Video Courses